Chimeric Antigen Receptor Signaling Domains Differentially Regulate Proliferation and Native T Cell Receptor Function in Virus-Specific T Cells-Reference-Cited by-同舟云学术

Chimeric Antigen Receptor Signaling Domains Differentially Regulate Proliferation and Native T Cell Receptor Function in Virus-Specific T Cells

Published:2018-12-11 Issue: Volume:5 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Omer Bilal,Castillo Paul A.,Tashiro Haruko,Shum Thomas,Huynh Mai T. A.,Cardenas Mara,Tanaka Miyuki,Lewis Andrew,Sauer Tim,Parihar Robin,Lapteva Natalia,Schmueck-Henneresse Michael,Mukherjee Malini,Gottschalk Stephen,Rooney Cliona M.

Funder

National Institutes of Health

Children's Neuroblastoma Cancer Foundation

Alex's Lemonade Stand Foundation for Childhood Cancer

V Foundation for Cancer Research

Publisher

Frontiers Media SA

Subject

General Medicine

Reference47 articles.

1. The basic principles of chimeric antigen receptor design;Sadelain;Cancer Disco.,2013

2. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial;Lee;Lancet,2015

3. Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor;Kochenderfer;J Clin Oncol.,2015

4. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N Engl J Med.,2014

5. Chimeric antigen receptor T-cell therapy for solid tumors;Newick;Mol Ther Oncol.,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GD2-targeting therapy: a comparative analysis of approaches and promising directions;Frontiers in Immunology;2024-03-15

2. The Progress and Prospects of Immune Cell Therapy for the Treatment of Cancer;Cell Transplantation;2024-01

3. Current approaches to develop “off-the-shelf” chimeric antigen receptor (CAR)-T cells for cancer treatment: a systematic review;Experimental Hematology & Oncology;2023-08-21

4. Joining Forces for Cancer Treatment: From “TCR versus CAR” to “TCR and CAR”;International Journal of Molecular Sciences;2022-11-23

5. A Costimulatory CAR Improves TCR-based Cancer Immunotherapy;Cancer Immunology Research;2022-02-16